Issues from global IR diagnosis only start to compound as improvement once they're carried back into the next quarter's investor-facing materials. Priorities organized through the diagnosis card and equity story design need to be reflected in results materials, English disclosure improvements, IR website updates, and investor-facing Q&A — under the same equity story. Our quarterly disclosure improvement connects the last meeting's questions and internally-agreed messaging into the next disclosure cycle, so improvement doesn't end as a one-off each quarter.
We organize which slide headings, order, and explanation granularity to change for the upcoming quarter.
Beyond wording adjustment, we align the explanation axis so investors reach the same understanding across channels.
We reflect likely questions in supporting materials and management messaging so the next prep round has updated answer material.
Rather than starting from zero each cycle, we narrow themes against the diagnosis card and design the loop into the next quarter.
We don't stop at listing issues — we specify what changes where in the next investor-facing materials.
Headlines and explanation order align across channels so the message doesn't shift in transmission.
Recurring meeting topics reflect into next materials and Q&A so the explanation is repeatable.
We present them as the causal chain investors need, not as separate items.
Not surface text edits — we tune material structure to how overseas investors actually read.
We don't make disclosure decisions on your behalf — we support the operational reflection of internally-agreed messaging.